Background: Recently, hydrochlorothiazide has been shown to relax vascular smooth muscle in vitro in clinically relevant concentrations by the opening of calcium-activated potassium channels, leading to hyperpolarization and consequent closing of voltage-operated calcium channels. Long-term administration of hydro chlorothiazide reduces peripheral vascular resistance in vivo in man. These results indicate that hydrochlorothiazide has hemodynamic activity, and we therefore examined the direct vascular action of this drug in vivo.
Introduction
Thiazide diurctics are widely used and considered treatment o f first choice in most patients with essential hypertension as they reduce the risk o f stroke and other cardiovascular events [1] . Evidence is accumu lating that their efficacy is at least partly due to a direct hemodynamic action. During chronic thiazide administration, the plasma volume returns to baseline and peripheral resistance decreases [2 ] , suggesting a vascular action besides the diuretic effects. Chronic treatment with thiazides has also been reported to reduce the vasoconstrictor action o f norepinephrine in both normotensives and hypertensive patients [3, 4] . An acute diuretic-induced fall in blood pressure is incidentally observed, dissociated from changes in plasma volume in patients with renal failure [5] , although there are no consistent data. [6 ] .
In animals, parenterally administered hydrochlorothiazide causes an immediate fall in blood pressure associated with inhibition o f the vasopressor response to stimu lation o f adrenergic vasomotor fibers, w hile prolonged treatment with hydrochlorothiazide in rabbits and dogs has been reported to inhibit norepinephrine-induced vasoconstriction both in vivo and in vitro

In the past few years concentration-dependent relaxant effects o f clinically relevant concentrations o f hydro chlorothiazide have been demonstrated in human and
guinea-pig isolated resistance arteries [7] . This vasodila tor activity is associated with a fall in intracellular Ca-+ [8 ] . Its action is inhibited by charybdotoxin, a blocker o f large-conductance Ca2+-activated K+channels but not by glibenclamide, a blocker of ATP-sensitive K+channels [7] . In summary, it seems that hydrochlorothiazide increases the permeability o f smooth muscle membranes to K+ [9] , probably by opening Ca2+-activated K+ channels, thereby leading to K+ efflux [10] and membrane hyperpolarization, and consequent closing o f voltage-operated Ca2+ channels and smooth muscle relaxation.
The present study was aimed at investigating the putative direct vascular effects of hydrochlorothiazide in humans in vivo.
Subjects and methods
The study protocol was approved by the Ethics C om mittee o f our hospital and informed written consent was obtained from each subject before participation. Eight healthy male volunteers were submitted to clinical examination before admission to the study. N one o f the subjects smoked or was on any kind o f medication. The age, weight, height, body mass index, forearm volume and systolic/diastolic blood pressure of these subjects were, respectively, 24,8 ± 5 .0 years, 78.5 ± 4 .7 kg, 186.0± 5.0 cm, 2 2 .7 ± 1.6 k g/m 2, 1088 ± 133 ml and 1 2 7 ± 9 /7 3 ± 9 m m H g . The subjects were instructed to follow their usual diets, but to abstain from chocolate and alcohol and caffeine-containing beverages 24 h preceding the experiment. Analysis o f variance for repeated measures was used to test for differences in forearm blood flow during the increasing drug concentrations. P < 0 .0 5 (two-sided) was considered significant. Fig. 1 
The experiments were performed during a 3-h im m o bilization period in the supine position in a quiet and temperature-controlled laboratory as descibed previously [11]. Briefly, the left brachial artery was cannulated for drug infusion and blood pressure monitoring. After occlusion o f the hand circulation, forearm blood flow was measured in both arms with venous occlusion plethysmography using mercury-in-silastic strain gauges. The forearm blood flow o f the contralateral arm was used as a time-control value so that systemic effects could be observed and vasoactive effects could be expressed as a quotient of the left and right arm [12]. Each infusion period lasted lOmin and was alternated with
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Ratios o f infused to control forearm blood flow and ipsilateral venous plasma concentrations o f hydrochloro thiazide are shown in
. During five increasing doses o f hydrochlorothiazide there was no significant effect on forearm blood flow compared to the placebo infusion. Using the data from the last 2 min o f infusion (instead o f the last 8 min) did not change these results. The vascular resistance (quotient o f blood pressure and forearm blood flow) o f the hydrochlorothiazide-infused
forearm averaged 68.7 ± 6.5 AU during placebo, rising to 8 6 . 6 ± 9 .2 A U at the highest dose (NS). Regional hydrochlorothiazide plasma concentrations ranged from 0.04 + 0.003 at the lowest dose to 3.5 ± 0 ,3 (ig/m l (comparable to 10 |LLmol/l) at the highest dose. The hydrochlorothiazide infusion o f 2 0 min in four subjects showed no significant effects on forearm blood flow or vascular resistance. Intra-arterial blood pressure and heart rate (respectively 1 2 4 ± 4 /6 4 ± 2 m n iH g and 58 ± 2 beats/min during the placebo and 128 ± 4 /6 7 ± 2 and 58 ± 3 during the highest hydrochlorothiazide dose) did not change significantly during the experiments.
Ratio Forearm Blood Flow
[HCTZ] lasm . f'g-l • Ratio of forearm blood flow in hydrochlorothiazide (HCTZ)-infused to control arm as measured by venous oc clusion plethysmography (left axis) and local venous hydro chlorothiazide concentrations during an intra-arterial infu sion of placebo and five increasing doses of hydrochloro thiazide (right axis). Values are expressed as means±SEM (n = 8).
Discussion
In contrast to in vitro experiments by our group [8 ] and others [7, 9, 10] , and studies on vasoactivity after long-term systemic administration [2] [3] [4] , the present study showed that the intra-arterial administration o f hydrochlorothiazide exerted no direct effects on the forearm vascular bed o f male normotensive volunteers. As expected with this technique, there were no blood pressure or heart rate changes during the experiments to suggest any acute effect. So, despite considerable evi dence that hydrochlorothiazide exerts direct vasoactivity, our in vivo findings suggest that in pharmacologically rel evant concentrations hydrochlorothiazide is not directly vasoactive in the forearm vascular bed.
At the highest infusion rate, the mean plasma con centration reached 3 .5 ± 0 .3 jig/m l (~10 p.mol/1). This concentration resulted in a 60 ± 1 0 % vasodilation in vitro o f human subcutaneous resistance vessels [7]
and was 1 0 -3 0 times the therapeutic plasma concentration in subjects with normal renal function [14] . The protein-bound fraction was not measured, but was expected to be in the normal range o f 22% [15] to 55% [16]. Thus, even after correction for the protein-bound fraction, the drug concentration remained well above therapeutic levels. In conclusion, in contrast to our in vitro observations, hydrochlorothiazide did not have a direct vasorelaxant effect in skeletal muscles in vivo in normotensive subjects.
There are a number o f potential explanations for this discrepancy between our in vitro and
